Latest Articles

Publication Date
397 ‒ Endometriosis and adenomyosis: diagnosis, fertility, reproductive aging, and emerging treatments | Renato Tomioka, M.D., Ph.D. - Peter Attia MD

397 ‒ Endometriosis and adenomyosis: diagnosis, fertility, reproductive aging, and emerging treatments | Renato Tomioka, M.D., Ph.D. Peter Attia MD

Published: June 22, 2026, 4:35 a.m.
Nociception-guided opioid administration within multimodal analgesia for laparoscopic endometriosis surgery: a randomized controlled trial.

Women with endometriosis are at increased risk of severe postoperative pain due to nociceptive sensitization. While multimodal analgesia reduces opioid use, the added value of objective nociception monitoring remains unclear. …

Published: June 22, 2026, midnight
Evaluation of the use of dienogest in women with deep endometriosis and ovarian endometrioma: a retrospective cohort study.

The aim of this study was to evaluate the use of dienogest in the treatment of deep endometriosis and ovarian endometrioma.

Published: June 22, 2026, midnight
Pain and functional outcomes after surgical versus hormonal treatment in rectovaginal endometriosis: a retrospective cohort study.

To compare changes in pain-related symptoms, bowel and bladder function, rectal bleeding, quality of life, and treatment satisfaction in women with rectovaginal endometriosis treated either surgically or with hormonal treatment …

Published: June 21, 2026, midnight
The role of anti-Müllerian hormone as a therapeutic agent to preserve the ovarian follicle pool during chemotherapy.

Cancer treatments can deplete the ovarian follicle reserve, causing infertility and early menopause, with subsequent decline in cardiovascular, cognitive, and overall women's health. Medical measures to prevent this chemotherapy-induced ovarian …

Published: June 20, 2026, midnight
Path beyond the blind end-unravel the imaging spectrum of appendiceal pathologies.

The appendix is involved in a diverse spectrum of inflammatory, infectious, benign, and malignant conditions that extend far beyond acute appendicitis. Although acute appendicitis remains the most common appendiceal emergency, …

Published: June 20, 2026, midnight
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer - Targeted Oncology

Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer Targeted Oncology

Published: June 19, 2026, 5:05 p.m.
Endometriosis and fibroids: Expert explains advances giving women less invasive treatment options - The Union Democrat

Endometriosis and fibroids: Expert explains advances giving women less invasive treatment options The Union Democrat

Published: June 19, 2026, 4:24 p.m.
Exploring Women's Experiences of Information Across Their Endometrial Cancer Diagnosis and Treatment - Docwire News

Exploring Women's Experiences of Information Across Their Endometrial Cancer Diagnosis and Treatment Docwire News

Published: June 19, 2026, 10:17 a.m.
Endometriosis and fibroids: Expert explains advances giving women less invasive treatment options - The Daily Gazette

Endometriosis and fibroids: Expert explains advances giving women less invasive treatment options The Daily Gazette

Published: June 19, 2026, 8 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!